This Monday, the European Commission announced that it was conducting an investigation into the Chinese online sales site AliExpress concerning the alleged distribution of illegal products, in particular fake medicines.
The Brussels executive explained that it had sent AliExpress a formal request for information on the measures taken by this subsidiary of the Chinese giant Alibaba in order to protect consumers in accordance with the new European legislation on digital services (DSA) which came into force at the end of August .